Atif, Fahim http://orcid.org/0000-0003-3943-6648
Yousuf, Seema
Espinosa-Garcia, Claudia
Stein, Donald G.
Article History
Received: 11 January 2021
Accepted: 31 March 2021
First Online: 13 April 2021
Declarations
:
: The use of human glioblastoma cell lines in this study was approved by the Institutional Animal Care and Use Committee, Emory University, Atlanta, GA, USA.
: All the authors have given consent to publish this study.
: A US patent (# US 8,435,972 B2) was issued to FA and DGS on May 7, 2013, for the use of P4 and compositions related thereto for the treatment of neurogenic tumors specially neuroblastoma and glioblastoma. At present, there are no commercial or financial claims related to the patent. Allen and Company is an investment firm with no commercial interests in pharmacology or any other matter relating to our research. The Marcus Foundation is a philanthropic foundation supporting research in developmental psychobiology and other related areas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.